期刊
NMR IN BIOMEDICINE
卷 26, 期 7, 页码 756-765出版社
WILEY
DOI: 10.1002/nbm.2872
关键词
nanoparticle; iron oxide; multimodality; multiscale; molecular imaging; MRI; PET; optical imaging
资金
- National Institutes of Health (NIH) [R01HL095629, R01HL096576, HHSN268201000044C]
- Deutsche Forschungsgemeinschaft (DFG) [HE6382/1-1]
Iron oxide core nanoparticles are attractive imaging agents because their material properties allow the tuning of pharmacokinetics as well as the attachment of multiple moieties to their surface. In addition to affinity ligands, these include fluorochromes and radioisotopes for detection with optical and nuclear imaging. As the iron oxide core can be detected by MRI, options for combining imaging modalities are manifold. Already, preclinical imaging strategies have combined noninvasive imaging with higher resolution techniques, such as intravital microscopy, to gain unprecedented insight into steady-state biology and disease. Going forward, hybrid iron oxide nanoparticles will help to merge modalities, creating a synergy that will enable imaging in basic research and, potentially, also in the clinic. Copyright (c) 2012 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据